Lazar David E. 4
4 · KALA BIO, Inc. · Filed Dec 22, 2025
Insider Transaction Report
Form 4
KALA BIO, Inc.KALA
Lazar David E.
DirectorChief Executive Officer
Transactions
- Other
Convertible Loan
2025-12-18−368,614→ 0 totalExercise: $1.02From: 2025-11-09→ Common Stock (368,614 underlying)
Holdings
- 0
Common Stock
Footnotes (3)
- [F1]No shares of common stock are beneficially owned.
- [F2]Not applicable.
- [F3]On November 9, 2025, the Reporting Person, as "Lender", entered into a Convertible Loan Agreement (the "Agreement") with Issuer pursuant to which Lender agreed to loan the Issuer up to an amount of $375,000. Pursuant to the Agreement, the Lender had the right in its discretion at any time prior to the full repayment of the Loan Amount (as defined in the Agreement) to the Lender, to convert all or any of the then outstanding and unpaid portion of the Loan Amount into Issuer's common stock at the "Conversion Price" (as defined in the Agreement). On December 18, 2025, the Issuer repaid the full Loan Amount to the Reporting Person in cash.